Medical Research Commercialisation Fund (MRCF)
25
5M
23
1.67
5
0.08
1
- Stages of investment
- Areas of investment
Summary
In 2007 was created Medical Research Commercialisation Fund (MRCF), which is appeared as VC. The main department of described VC is located in the Melbourne. The company was established in Australia.
The overall number of key employees were 1.
This Medical Research Commercialisation Fund (MRCF) works on 24 percentage points less the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2014. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars. Speaking about the real fund results, this VC is 4 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2013. Despite it in 2019 the fund had an activity.
The fund has exact preference in some founders of portfolio startups. If startup sums 2 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Australia. Among the most popular portfolio startups of the fund, we may highlight Paragen Bio, OncoRes Medical, OccuRx. Among the most popular fund investment industries, there are Biotechnology, Medical Device.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Medical Research Commercialisation Fund (MRCF), startups are often financed by State Government of Victoria, Brandon Capital Partners. The meaningful sponsors for the fund in investment in the same round are Uniseed Ventures, OneVentures, Brandon Capital Partners. In the next rounds fund is usually obtained by Pitch@Palace, OneVentures, Imperial Innovations.
Investments analytics
Analytics
- Total investments
- 25
- Lead investments
- 5
- Exits
- 1
- Rounds per year
- 1.67
- Follow on index
- 0.08
- Investments by industry
- Biotechnology (17)
- Health Care (15)
- Medical (14)
- Therapeutics (6)
- Medical Device (6) Show 11 more
- Investments by region
-
- Australia (17)
- Israel (2)
- United States (2)
- United Kingdom (3)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.88
- Avg. company exit year
- 8
- Avg. multiplicator
- 14.07
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| 13 Mar 2006 | 6M | ||||
| Denteric | 26 Sep 2019 | Health Care | Early Stage Venture | 10M | Melbourne, Victoria, Australia |
| Q-Sera | 01 Jan 2013 | Health Care, Medical Device, Medical | Seed | Victoria, Melbourne, Australia | |
| Zygo | 14 Mar 2022 | Fitness, Wellness, Sports, Hardware, Wearables, Swimming | Seed | 2M | United States, California, Los Angeles |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.